A simple blood test for the protein NT-proBNP accurately predicts the risk of heart attack, heart failure, stroke, and death in patients with known cardiovascular disease, according to a study led by ...

Dallas, TX - The addition of natriuretic peptide testing to the traditional clinical evaluation of patients with dyspnea of suspected cardiac origin cut the duration of emergency-department visits by ...

BNP may help doctors identify HCM patients at highest risk of serious heart complications, improving monitoring and treatment ...

LONDON, Jan. 31, 2023 (GLOBE NEWSWIRE) -- LumiraDx Limited, a next-generation point of care diagnostics company, today announced it has commenced commercial shipment of its point of care NT-proBNP ...

Blood pressure cuff Elevated NT-proBNP may represent a useful biomarker for the identification of individuals at high risk for CVD and mortality across the spectrum of blood and pulse pressures.

Exclusive: Scientists find a way to forecast hypertrophic cardiomyopathy, which affects millions worldwide Scientists are developing a simple blood test to predict who is most at risk from the world’s ...

Run on the highly portable LumiraDx Platform, the LumiraDx NT-proBNP test is a quantitative, fingerstick blood assay designed for near-patient testing with lab-comparable results in 12 minutes. It is ...